‘Reprehensible choice:’ Tobacco firm Philip Morris’s controversial bid for asthma firm goes to auction
“We are also deeply troubled that this company could further profit from the disease their products have caused by now selling therapies to the same people who were sickened by smoking PMI cigarettes," said the American Lung Association.








